Zoladex 10.8 mg (Goserelin 10.8 mg) by AstraZeneca.
Indications: Advanced and locally advanced prostate cancer; selected hormone-dependent conditions per SmPC.
Administration: Subcutaneous implant into the anterior abdominal wall every 12 weeks.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | AstraZeneca |
| Active ingredient | Goserelin 10.8 mg (as acetate) — LHRH agonist depot implant. |
| Strength & pack | 1 pre-filled SafeSystem syringe applicator. |
| Form | Implant in pre-filled syringe |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |